[1]Buie MJ, Quan J, Windsor JW, et al. Global hospitalization trends for crohn's disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses[J]. Clin Gastroenterol Hepatol, 2023, 21(9):2211-2221. DOI: 10.1016/j.cgh.2022.06.030.
[2]Xu L, He B, Sun Y, et al. Incidence of inflammatory bowel disease in urban China: a nationwide population-based study[J]. Clin Gastroenterol Hepatol, 2023, 21(13): 3379-3386. DOI: 10.1016/j.cgh.2023.08.013.
[3]Spinelli A, Bonovas S, Burisch J, et al. ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment [J]. J Crohns Colitis, 2022, 16(2):179-189. DOI: 10.1093/ecco-jcc/jjab177.
[4]徐明.理气清肠方加减联合美沙拉嗪治疗溃疡性结肠炎的效果[J].国际医药卫生导报, 2022, 28(3): 410-413. DOI: 10.3760/cma.j.issn.1007-1245.2022.03.027.
[5]Cui Q, Liu HC, Liu WM, et al. Milk fat globule epidermal growth factor 8 alleviates liver injury in severe acute pancreatitis by restoring autophagy flux and inhibiting ferroptosis in hepatocytes[J]. World J Gastroenterol, 2024, 30(7): 728-741. DOI: 10.3748/wjg.v30.i7.728.
[6]王迪,龙世群. Mac-2BP联合FUC-HPT对慢性肝炎患者病情严重程度的诊断价值[J].检验医学与临床, 2020, 17(6):784-787. DOI: 10.3969/j.issn.1672-9455.2020.06.019.
[7]Huang CL, Achudhan D, Liu PI, et al. Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling[J]. Aging (Albany NY), 2023, 15(11): 4774-4793. DOI: 10.18632/aging.204762.
[8]中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年•北京)[J].中国实用内科杂志, 2018, 38(9):796-813. DOI: 10.19538/j.nk2018090106.
[9]Gui X, Bazarova A, Del Amor R, et al. PICaSSO histologic remission index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system[J]. Gut, 2022, 71(5): 889-898. DOI: 10.1136/gutjnl-2021-326376.
[10]Caliendo G, D'Elia G, Makker J, et al. Biological, genetic and epigenetic markers in ulcerative colitis[J]. Adv Med Sci, 2023, 68(2): 386-395. DOI: 10.1016/j.advms. 2023.09.010.
[11]Gao X, Huang D, Yang LS, et al. Identification of gut microbiome and transcriptome changes in ulcerative colitis and pouchitis[J]. Scand J Gastroenterol, 2022, 57(8):942-952. DOI: 10.1080/00365521.2022.2047221.
[12]Li YY, Wang XJ, Su YL, et al. Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s[J]. Acta Pharmacol Sin, 2022, 43(6):1495-1507. DOI: 10.1038/s41401-021- 00781-7.
[13]李湘成,郭感恩,赵洁,等.血清PCT、NETs、MFG-E8、TLR 9与重症急性胰腺炎患者肠黏膜屏障功能的相关性分析及对预后的影响[J].现代生物医学进展,2023,23(5):963-968. DOI:10.13241/j.cnki.pmb.2023.05.033.
[14]Motooka K, Morishita K, Ito N, et al. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis[J]. World J Gastroenterol, 2021, 27(2): 162-175. DOI: 10.3748/wjg.v27.i2.162.
[15]Morshedzadeh N, Rahimlou M, Shahrokh S, et al. The effects of flaxseed supplementation on concentration of circulating adipokines in patients with ulcerative colitis[J]. Gastroenterol Hepatol Bed Bench, 2023, 16(1): 458-467. DOI: 10.22037/ghfbb.v16i1.2622.
[16]李霞,周宇,汤欣源. CDX2,miR-204-5p在溃疡性结肠炎患者黏膜组织中的表达及其与预后的关系[J].海南医学, 2022, 33(19): 2456-2459. DOI: 10.3969/j.issn. 1003-6350.2022.19.003.
[17]陶琴琴,赵亚静,杨晓明. microRNA-192表达量与溃疡性结肠炎患者炎性反应及预后的相关性[J].临床消化病杂志, 2024, 36(1): 16-21. DOI: 10.3870/lcxh.j.issn.1005- 541X.2024.01.004.
[18]Kozioł K, Owczarek D, Cibor D, et al. Serum level of lactadherin (MFGE8) in inflamatory bowel disease[J]. Folia Med Cracov, 2023, 63(3): 15-29. DOI: 10.24425/fmc.2023.147212.
[19]García-Alanis M, Toapanta-Yanchapaxi L, Reyes-Velásquez A, et al. The interrelation between anxiety and quality of life among patients with ulcerative colitis in remission[J]. Gastroenterol Hepatol, 2023, 46(10):747-753. DOI: 10.1016/j.gastrohep.2023.01.003.
[20]El-Zimaity H, Shaffer SR, Riddell RH, et al. Beyond neutrophils for predicting relapse and remission in ulcerative colitis[J]. J Crohns Colitis, 2023, 17(5):767-776. DOI: 10.1093/ecco-jcc/jjac178.
|